Enlarged prostate or prostate cancer? Both can cause urinary symptoms, yet one is benign and never raises your cancer risk. Here's how the two truly differ.

BRCA prostate cancer can change everything from screening to treatment—BRCA2 carries the highest risk, and a mutation may open targeted PARP therapy.

A prostate cancer diet works through your overall pattern and weight, not any single food — and some supplements can do more harm than good.

Prostate cancer statistics for 2026 show a 1 in 8 lifetime risk — but only 1 in 44 men die of it. Here's what the latest US numbers really mean.

Prostate cancer survival rates vary by stage — from over 99% for localized disease to 38% once it spreads. Here's what the numbers mean for you.

Metastatic prostate cancer has a 38% 5-year survival rate—but that average doesn't predict any one person's outlook. Here's how to read it.

Prostate cancer recurrence usually shows up first as a rising PSA — not symptoms. Here's how doctors read the threshold, doubling time, and PSMA PET scans.

Leaking urine after prostatectomy is expected — and usually temporary. Here's the honest recovery timeline, from catheter removal to the 12-month mark.

Erectile dysfunction after prostate cancer is common but often manageable — and recovery odds rise sharply for younger men with nerve-sparing surgery.

Choosing between prostate cancer surgery and radiation? Survival is nearly the same for both—what differs is the side-effect trade-off.